Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from MedAdvisor Limited ( (AU:MDR) ).
MedAdvisor Limited has announced the issuance of 1,750,000 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX) on November 6, 2025. This move is part of a previously announced transaction and is expected to impact the company’s market presence by increasing its available securities, potentially enhancing liquidity and investor interest.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, providing digital health solutions primarily focused on medication management. The company offers platforms and services that enhance the efficiency of medication adherence and management for patients, healthcare professionals, and pharmacies.
Average Trading Volume: 845,769
Technical Sentiment Signal: Sell
Current Market Cap: A$16.45M
See more data about MDR stock on TipRanks’ Stock Analysis page.